Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biomarkers.
Smith A, Plastini MJ, Ashton NJ, Montoliu-Gaya L, Wilson EN, Arslan B, Young CB, Winer JR, Shahid M, Vossler H, Kerchner GA, Cholerton B, Andreasson KI, Yutsis M, Henderson VW, Montine TJ, Tian L, Mormino E, Zetterberg H, Poston KL, Abdelnour C. Smith A, et al. Among authors: kerchner ga. Alzheimers Dement. 2024 Dec;20 Suppl 2:e091458. doi: 10.1002/alz.091458. Alzheimers Dement. 2024. PMID: 39785408
Developing Topics.
Bateman RJ, Li Y, McDade E, Llibre-Guerra JJ, Clifford DB, Atri A, Mills S, Santacruz A, Wang G, Supnet CB, Benzinger TLS, Gordon BA, Ibanez L, Klein G, Baudler M, Doody RS, Kerchner GA. Bateman RJ, et al. Among authors: kerchner ga. Alzheimers Dement. 2024 Dec;20 Suppl 8:e094602. doi: 10.1002/alz.094602. Alzheimers Dement. 2024. PMID: 39783668 Clinical Trial.
Developing Topics.
Ibanez L, Li Y, McDade E, Llibre-Guerra JJ, Clifford DB, Mills S, Santacruz A, Wang G, Supnet-Bell C, Benzinger TLS, Gordon BA, Klein G, Baudler M, Doody RS, Kerchner GA, Bittner T, Atri A, Bateman RJ. Ibanez L, et al. Among authors: kerchner ga. Alzheimers Dement. 2024 Dec;20 Suppl 8:e094831. doi: 10.1002/alz.094831. Alzheimers Dement. 2024. PMID: 39783556 Clinical Trial.
Developing Topics.
Atri A, Llibre-Guerra JJ, Clifford DB, McDade E, Li Y, Mills S, Santacruz A, Wang G, Supnet CB, Benzinger TLS, Gordon BA, Ibanez L, Wojtowicz J, Klein G, Baudler M, Kerchner GA, Bateman RJ. Atri A, et al. Among authors: kerchner ga. Alzheimers Dement. 2024 Dec;20 Suppl 8:e094833. doi: 10.1002/alz.094833. Alzheimers Dement. 2024. PMID: 39783522
Developing Topics.
Benzinger TLS, Gordon BA, McCullough AA, Hornbeck RC, Flores S, Koeppe RA, Jack CR Jr, Li Y, McDade E, Llibre-Guerra JJ, Clifford DB, Mills S, Santacruz A, Wang G, Supnet-Bell C, Ibanez L, Klein G, Baudler M, Doody RS, Kerchner GA, Atri A, Bateman RJ; DIAN‐TU Study Team. Benzinger TLS, et al. Among authors: kerchner ga. Alzheimers Dement. 2024 Dec;20 Suppl 8:e094832. doi: 10.1002/alz.094832. Alzheimers Dement. 2024. PMID: 39783508 Clinical Trial.
Plasma Aβ42/Aβ40 is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum.
Trelle AN, Young CB, Vossler H, Ramos Benitez J, Cody KA, Mendiola JH, Swarovski MS, Guen YL, Feinstein I, Butler RR 3rd, Channappa D, Romero A, Park J, Shahid-Besanti M, Corso NK, Chau K, Smith AN, Skylar-Scott I, Yutsis MV, Fredericks CA, Tian L, Younes K, Kerchner GA, Deutsch GK, Davidzon GA, Sha SJ, Henderson VW, Longo FM, Greicius MD, Wyss-Coray T, Andreasson KI, Poston KL, Wagner AD, Mormino EC, Wilson EN. Trelle AN, et al. Among authors: kerchner ga. Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14442. Online ahead of print. Alzheimers Dement. 2024. PMID: 39713875
Long-term safety of gantenerumab in participants with Alzheimer's disease: A phase III, open-label extension study (SCarlet RoAD).
Boada M, Neve A, Das B, Wojtowicz J, Huang Z, Bullain S, Watkin M, Lott D, Bittner T, Delmar P, Klein G, Hofmann C, Kerchner GA, Smith J, Baudler M, Fontoura P, Doody RS. Boada M, et al. Among authors: kerchner ga. J Alzheimers Dis. 2024 Dec 16:13872877241303644. doi: 10.1177/13872877241303644. Online ahead of print. J Alzheimers Dis. 2024. PMID: 39686620
Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial.
Pagano G, Monnet A, Reyes A, Ribba B, Svoboda H, Kustermann T, Simuni T, Postuma RB, Pavese N, Stocchi F, Brockmann K, Smigorski K, Gerbaldo V, Fontoura P, Doody R, Kerchner GA, Brundin P, Marek K, Bonni A, Nikolcheva T; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Among authors: kerchner ga. Nat Med. 2024 Dec;30(12):3669-3675. doi: 10.1038/s41591-024-03270-6. Epub 2024 Oct 8. Nat Med. 2024. PMID: 39379705 Free PMC article. Clinical Trial.
Long-Term Safety of Gantenerumab in Participants with Alzheimer's Disease: A Phase III, Double-Blind, and Open-Label Extension Study (Marguerite RoAD).
Neve A, Das B, Wojtowicz J, Huang Z, Bullain S, Watkin M, Lott D, Bittner T, Delmar P, Klein G, Hofmann C, Kerchner GA, Smith J, Baudler M, Fontoura P, Doody RS. Neve A, et al. Among authors: kerchner ga. J Alzheimers Dis. 2024;101(1):353-367. doi: 10.3233/JAD-240221. J Alzheimers Dis. 2024. PMID: 39177596 Free PMC article. Clinical Trial.
84 results